FDA Approves of BYETTA™ (Exenatide) Injection for Type 2 Diabetes, drug derived from Gila monster
Sat, 30 Apr 2005 04:00 AM EST
... The US FDA has approved BYETTA™ (exenatide) injection as adjunctive therapy to improve blood sugar control in patients with type 2 diabetes who have not achieved adequate control on metformin and/or a sulfonylurea, two common oral diabetes medications... click link for more info. ...
Related Topics
- Diabetes - Type 1
- Diabetes - Type 2
- Juvenile Diabetes
- Diabetes and Pregnancy
- Drug Safety
- Diabetes Insipidus
- Gestational Diabetes
- Diabetes
- Rosiglitazone
- Prescription Drugs
- Insulin
- Clinical Trials
- Type 1 diabetes
- Type 2 diabetes
- Diabetes Type 1
- Drug Side Effects
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse

Not Signed In -


